Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Mar;28(1):108-118.
doi: 10.1111/jns.12530. Epub 2023 Jan 20.

INF2 mutations in patients with a broad phenotypic spectrum of Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis

Jin Hee Park  1 , Hye Mi Kwon  2 , Da Eun Nam  1 , Hye Jin Kim  2 , Soo Hyun Nam  2   3 , Sang Beom Kim  4 , Byung-Ok Choi  2   3   5 , Ki Wha Chung  1
Affiliations
Case Reports

INF2 mutations in patients with a broad phenotypic spectrum of Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis

Jin Hee Park et al. J Peripher Nerv Syst. 2023 Mar.

Abstract

Mutations in INF2 are associated with the complex symptoms of Charcot-Marie-Tooth disease (CMT) and focal segmental glomerulosclerosis (FSGS). To date, more than 100 and 30 genes have been reported to cause these disorders, respectively. This study aimed to identify INF2 mutations in Korean patients with CMT. This study was conducted with 743 Korean families with CMT who were negative for PMP22 duplication. In addition, a family with FSGS was included in this study. INF2 mutations were screened using whole exome sequencing (WES) and filtering processes. As the results, four pathogenic INF2 mutations were identified in families with different clinical phenotypes: p.L78P and p.L132P in families with symptoms of both CMT and FSGS; p.C104Y in a family with CMT; and p.R218Q in a family with FSGS. Moreover, different CMT types were observed in families with CMT symptoms: CMT1 in two families and Int-CMT in another family. Hearing loss was observed in two families with CMT1. Pathogenicity was predicted by in silico analyses, and considerable conformational changes were predicted in the mutant proteins. Two mutations (p.L78P and p.C104Y) were unreported, and three families showed de novo mutations that were putatively occurred from fathers. This study suggests that patients with INF2 mutations show a broad phenotypic spectrum: CMT1, CMT1 + FSGS, CMTDIE + FSGS, and FSGS. Therefore, the genotype-phenotype correlation may be more complex than previously recognized. We believe that this study expands the clinical spectrum of patients with INF2 mutations and will be helpful in the molecular diagnosis of CMT and FSGS.

Keywords: Charcot-Marie-Tooth disease; INF2; Korean; focal segmental glomerulosclerosis; phenotypic spectrum.

PubMed Disclaimer

References

REFERENCES

    1. Candayan A, Parman Y, Battaloğlu E. Clinical and genetic survey for Charcot-Marie-tooth neuropathy based on the findings in Turkey, a country with a high rate of consanguineous marriages. Balkan Med J. 2022;39:3-11.
    1. Boyer O, Nevo F, Plaisier E, et al. INF2 mutations in Charcot-Marie-tooth disease with glomerulopathy. New Engl J Med. 2011;365:2377-2388.
    1. Mademan I, Deconinck T, Dinopoulos A, et al. De novo INF2 mutations expand the genetic spectrum of hereditary neuropathy with glomerulopathy. Neurology. 2013;81:1953-1958.
    1. Rodriguez PQ, Lohkamp B, Celsi G, et al. Novel INF2 mutation p. L77P in a family with glomerulopathy and Charcot-Marie-tooth neuropathy. Pediatr Nephrol. 2013;28:339-343.
    1. Chesarone MA, DuPage AG, Goode BL. Unleashing formins to remodel the Actin and microtubule cytoskeletons. Nat Rev Mol Cell Biol. 2010;11:62-74.

Publication types

MeSH terms